Free Mallinckrodt Drugs Risk Kickback Fines, Watchdog Says
Mallinckrodt PLC could face Anti-Kickback Statute sanctions under its plan to offer free vials of anti-seizure drug H.P. Acthar Gel, the Office of Inspector General for the U.S. Department of Health...To view the full article, register now.
Already a subscriber? Click here to view full article